A retrospective multicenter study of sublingual gland carcinoma in Japan

Tsuyoshi Kojima; Ryusuke Hori; Shinzo Tanaka; Hisanobu Tamaki; Ryo Asato; Morimasa Kitamura; Ichiro Tateya; Shogo Shinohara; Shinji Takebayashi; Toshiki Maetani; Yoshiharu Kitani; Yohei Kumabe; Koji Ushiro; Kazuyuki Ichimaru; Keigo Honda; Masanobu Mizuta; Koichiro Yamada; Koichi Omori

doi:10.1016/j.anl.2019.04.006

A retrospective multicenter study of sublingual gland carcinoma in Japan

Tsuyoshi Kojima, Ryusuke Hori, Shinzo Tanaka, Hisanobu Tamaki, Ryo Asato, Morimasa Kitamura, Ichiro Tateya, Shogo Shinohara, Shinji Takebayashi, Toshiki Maetani, Yoshiharu Kitani, Yohei Kumabe, Koji Ushiro, Kazuyuki Ichimaru, Keigo Honda, Masanobu Mizuta, Koichiro Yamada, Koichi Omori

耳鼻咽喉科学Ⅰ

研究成果: Article › 査読

1 被引用数 (Scopus)

抄録

Objective: Salivary gland carcinoma is rare among head and neck cancers. Sublingual gland carcinoma, a type of salivary gland carcinoma, is even rarer; therefore, the number of cases at a single institute is too small for sufficient evaluation of tumor characteristics. We conducted a multicenter, retrospective analysis of sublingual gland carcinomas in patients who visited 12 institutions associated with the Kyoto Hospital and Affiliated Facilities Head and Neck Clinical Oncology Group. Methods: Thirteen previously untreated patients who visited the institutions between 2006 and 2015 were enrolled. The overall survival (OS) and disease-free survival (DFS) rates for all patients and by disease stage were analyzed. Statistical analyses were performed for all patients with respect to disease stage. Results: Eight of thirteen patients were diagnosed with adenoid cystic carcinoma on pathological study. A significant difference in OS rate was observed between patients with Stage I–III and Stage IV disease; however, the difference in DFS rate by disease stage was not significant. Conclusion: Stage IV disease was identified as a poor prognostic factor in patients with sublingual gland carcinoma. However, even patients with Stage I–III disease experienced relatively short DFS. Distant metastasis is a serious problem among patients with sublingual gland carcinoma.

本文言語	English
ページ（範囲）	111-115
ページ数	5
ジャーナル	Auris Nasus Larynx
巻	47
号	1
DOI	https://doi.org/10.1016/j.anl.2019.04.006
出版ステータス	Published - 02-2020

All Science Journal Classification (ASJC) codes

Surgery
Otorhinolaryngology

文献へのアクセス

10.1016/j.anl.2019.04.006

他のファイルとリンク

フィンガープリント「A retrospective multicenter study of sublingual gland carcinoma in Japan」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Kojima, T., Hori, R., Tanaka, S., Tamaki, H., Asato, R., Kitamura, M., Tateya, I., Shinohara, S., Takebayashi, S., Maetani, T., Kitani, Y., Kumabe, Y., Ushiro, K., Ichimaru, K., Honda, K., Mizuta, M., Yamada, K., & Omori, K. (2020). A retrospective multicenter study of sublingual gland carcinoma in Japan. Auris Nasus Larynx, 47(1), 111-115. https://doi.org/10.1016/j.anl.2019.04.006

Kojima, Tsuyoshi ; Hori, Ryusuke ; Tanaka, Shinzo ; Tamaki, Hisanobu ; Asato, Ryo ; Kitamura, Morimasa ; Tateya, Ichiro ; Shinohara, Shogo ; Takebayashi, Shinji ; Maetani, Toshiki ; Kitani, Yoshiharu ; Kumabe, Yohei ; Ushiro, Koji ; Ichimaru, Kazuyuki ; Honda, Keigo ; Mizuta, Masanobu ; Yamada, Koichiro ; Omori, Koichi. / A retrospective multicenter study of sublingual gland carcinoma in Japan. In: Auris Nasus Larynx. 2020 ; Vol. 47, No. 1. pp. 111-115.

@article{4d370e23e2e0400f9d3eb08697f7193b,

title = "A retrospective multicenter study of sublingual gland carcinoma in Japan",

abstract = "Objective: Salivary gland carcinoma is rare among head and neck cancers. Sublingual gland carcinoma, a type of salivary gland carcinoma, is even rarer; therefore, the number of cases at a single institute is too small for sufficient evaluation of tumor characteristics. We conducted a multicenter, retrospective analysis of sublingual gland carcinomas in patients who visited 12 institutions associated with the Kyoto Hospital and Affiliated Facilities Head and Neck Clinical Oncology Group. Methods: Thirteen previously untreated patients who visited the institutions between 2006 and 2015 were enrolled. The overall survival (OS) and disease-free survival (DFS) rates for all patients and by disease stage were analyzed. Statistical analyses were performed for all patients with respect to disease stage. Results: Eight of thirteen patients were diagnosed with adenoid cystic carcinoma on pathological study. A significant difference in OS rate was observed between patients with Stage I–III and Stage IV disease; however, the difference in DFS rate by disease stage was not significant. Conclusion: Stage IV disease was identified as a poor prognostic factor in patients with sublingual gland carcinoma. However, even patients with Stage I–III disease experienced relatively short DFS. Distant metastasis is a serious problem among patients with sublingual gland carcinoma.",

author = "Tsuyoshi Kojima and Ryusuke Hori and Shinzo Tanaka and Hisanobu Tamaki and Ryo Asato and Morimasa Kitamura and Ichiro Tateya and Shogo Shinohara and Shinji Takebayashi and Toshiki Maetani and Yoshiharu Kitani and Yohei Kumabe and Koji Ushiro and Kazuyuki Ichimaru and Keigo Honda and Masanobu Mizuta and Koichiro Yamada and Koichi Omori",

note = "Funding Information: This work was not funded by any grant other than our clinical salaries at each hospital. ",

year = "2020",

month = feb,

doi = "10.1016/j.anl.2019.04.006",

language = "English",

volume = "47",

pages = "111--115",

journal = "Auris Nasus Larynx",

issn = "0385-8146",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

Kojima, T, Hori, R, Tanaka, S, Tamaki, H, Asato, R, Kitamura, M, Tateya, I, Shinohara, S, Takebayashi, S, Maetani, T, Kitani, Y, Kumabe, Y, Ushiro, K, Ichimaru, K, Honda, K, Mizuta, M, Yamada, K & Omori, K 2020, 'A retrospective multicenter study of sublingual gland carcinoma in Japan', Auris Nasus Larynx, vol. 47, no. 1, pp. 111-115. https://doi.org/10.1016/j.anl.2019.04.006

A retrospective multicenter study of sublingual gland carcinoma in Japan. / Kojima, Tsuyoshi; Hori, Ryusuke; Tanaka, Shinzo; Tamaki, Hisanobu; Asato, Ryo; Kitamura, Morimasa; Tateya, Ichiro; Shinohara, Shogo; Takebayashi, Shinji; Maetani, Toshiki; Kitani, Yoshiharu; Kumabe, Yohei; Ushiro, Koji; Ichimaru, Kazuyuki; Honda, Keigo; Mizuta, Masanobu; Yamada, Koichiro; Omori, Koichi.

In: Auris Nasus Larynx, Vol. 47, No. 1, 02.2020, p. 111-115.

研究成果: Article › 査読

TY - JOUR

T1 - A retrospective multicenter study of sublingual gland carcinoma in Japan

AU - Kojima, Tsuyoshi

AU - Hori, Ryusuke

AU - Tanaka, Shinzo

AU - Tamaki, Hisanobu

AU - Asato, Ryo

AU - Kitamura, Morimasa

AU - Tateya, Ichiro

AU - Shinohara, Shogo

AU - Takebayashi, Shinji

AU - Maetani, Toshiki

AU - Kitani, Yoshiharu

AU - Kumabe, Yohei

AU - Ushiro, Koji

AU - Ichimaru, Kazuyuki

AU - Honda, Keigo

AU - Mizuta, Masanobu

AU - Yamada, Koichiro

AU - Omori, Koichi

N1 - Funding Information: This work was not funded by any grant other than our clinical salaries at each hospital.

PY - 2020/2

Y1 - 2020/2

N2 - Objective: Salivary gland carcinoma is rare among head and neck cancers. Sublingual gland carcinoma, a type of salivary gland carcinoma, is even rarer; therefore, the number of cases at a single institute is too small for sufficient evaluation of tumor characteristics. We conducted a multicenter, retrospective analysis of sublingual gland carcinomas in patients who visited 12 institutions associated with the Kyoto Hospital and Affiliated Facilities Head and Neck Clinical Oncology Group. Methods: Thirteen previously untreated patients who visited the institutions between 2006 and 2015 were enrolled. The overall survival (OS) and disease-free survival (DFS) rates for all patients and by disease stage were analyzed. Statistical analyses were performed for all patients with respect to disease stage. Results: Eight of thirteen patients were diagnosed with adenoid cystic carcinoma on pathological study. A significant difference in OS rate was observed between patients with Stage I–III and Stage IV disease; however, the difference in DFS rate by disease stage was not significant. Conclusion: Stage IV disease was identified as a poor prognostic factor in patients with sublingual gland carcinoma. However, even patients with Stage I–III disease experienced relatively short DFS. Distant metastasis is a serious problem among patients with sublingual gland carcinoma.

AB - Objective: Salivary gland carcinoma is rare among head and neck cancers. Sublingual gland carcinoma, a type of salivary gland carcinoma, is even rarer; therefore, the number of cases at a single institute is too small for sufficient evaluation of tumor characteristics. We conducted a multicenter, retrospective analysis of sublingual gland carcinomas in patients who visited 12 institutions associated with the Kyoto Hospital and Affiliated Facilities Head and Neck Clinical Oncology Group. Methods: Thirteen previously untreated patients who visited the institutions between 2006 and 2015 were enrolled. The overall survival (OS) and disease-free survival (DFS) rates for all patients and by disease stage were analyzed. Statistical analyses were performed for all patients with respect to disease stage. Results: Eight of thirteen patients were diagnosed with adenoid cystic carcinoma on pathological study. A significant difference in OS rate was observed between patients with Stage I–III and Stage IV disease; however, the difference in DFS rate by disease stage was not significant. Conclusion: Stage IV disease was identified as a poor prognostic factor in patients with sublingual gland carcinoma. However, even patients with Stage I–III disease experienced relatively short DFS. Distant metastasis is a serious problem among patients with sublingual gland carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=85065574696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065574696&partnerID=8YFLogxK

U2 - 10.1016/j.anl.2019.04.006

DO - 10.1016/j.anl.2019.04.006

M3 - Article

C2 - 31104870

AN - SCOPUS:85065574696

VL - 47

SP - 111

EP - 115

JO - Auris Nasus Larynx

JF - Auris Nasus Larynx

SN - 0385-8146

IS - 1

ER -